Zinc greatly protects against bacterial pneumonia

Zinc greatly protects against bacterial pneumonia Zinc greatly protects against bacterial pneumonia They found that mice with lower zinc intake succumbed to infection up to three times faster because their immune systems had insufficient zinc to aid in killing the bacteria. Bart A. Eijkelkamp, Jacqueline R. Morey, Stephanie L. Neville, Aimee Tan, Victoria G. Pederick,…

Dosing schedule of pneumococcal vaccine linked with increased risk of getting multiresistant strain

Public release date: 7-Sep-2010 – EEV: Requested Re-Post from the HRR site. – Infants who received heptavalent pneumococcal conjugate vaccination (PCV-7) at 2, 4, and 11 months were more likely than unvaccinated controls to have nasopharyngeal acquisition of pneumococcal serotype 19A – the increase in serotype 19A disease was associated in time with the widespread…

How zinc starves lethal bacteria to stop infection

Contact: Dr Christopher McDevitt christopher.mcdevitt@adelaide.edu.au 61-449-823-946 University of Adelaide Australian researchers have found that zinc can ‘starve’ one of the world’s most deadly bacteria by preventing its uptake of an essential metal. The finding, by infectious disease researchers at the University of Adelaide and The University of Queensland, opens the way for further work to…

Dosing schedule of pneumococcal vaccine linked with increased risk of getting multiresistant strain

Β 2010 study posted for filing Contact: Elisabeth A. M. Sanders, M.D., Ph.D. l.sanders@umcutrecht.nl JAMA and Archives Journals This release is also available in Chinese on EurekAlert! Chinese. Infants who received heptavalent pneumococcal conjugate vaccination (PCV-7) at 2, 4, and 11 months were more likely than unvaccinated controls to have nasopharyngeal (in the nasal passages and…

Pneumococcal vaccine does not appear to protect against pneumonia: ” a systematic review and meta-analysis, looked at 22 clinical trials, reviews and meta-analyses and more than 100,000 participants “

2009 study posted for filing Contact: Kim Barnhardt kim.barnhardt@cmaj.ca 613-731-8610 x2224 Canadian Medical Association Journal Commonly used pneumococcal polysaccharide vaccines do not appear to be effective for preventing pneumonia, found a study by a team of researchers from Switzerland and the United Kingdom http://www.cmaj.ca/press/pg48.pdf. In many industrialized countries, polysaccharide pneumococcal vaccines (PPVs) are currently recommended…

Pneumococcal disease rates down significantly post-vaccine: But One of the non-vaccine strains, 19A showed an increase of 264%

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology Pneumococcal disease rates down significantly post-vaccine Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease (IPD) are down significantly in all age groups, while rates of IPD caused by non-vaccine strains are modestly on the rise.Β …